Results of a recently published long-term follow-up of the ASAP trial, which was conducted at universities and clinics across Germany, show that the genetic risk of disease, not remission status, ...

Brayden Cabral has been in remission for some time but he serves as inspirations for others who have gone or will go through a similar experience.

New research maps how bone marrow changes in acute myeloid leukemia disrupt neutrophil development and boost the risk for infection.

A research team at Lund University in Sweden has discovered a mechanism that helps acute myeloid leukemia cells to evade the body's immune system. By developing an antibody that blocks the mechanism, ...

A research team at Lund University in Sweden has discovered a mechanism that helps acute myeloid leukemia cells to evade the body’s immune system. By developing an antibody that blocks the mechanism, ...

Spontaneous regression of cancer is an uncommon event observed most often in neuroblastoma, leukemia, lung cancer, and melanoma. The underlying mechanisms are not fully understood; however, infections ...

Ziftomenib showed significant efficacy in relapsed/refractory NPM1-mutant AML, achieving deep, durable responses in the KOMET-001 trial. The trial enrolled 92 patients, with 23% achieving complete ...

Researchers have discovered a mechanism that helps acute myeloid leukemia cells to evade the body’s immune system. By developing an antibody that blocks the mechanism, the researchers could restore ...

Leukemia cells evade immune attack via SLAMF6, and by blocking this protein with a new antibody, researchers restored T cell function in AML.

A native of Southern California and a Crespi Carmelite High School graduate, Kyle Owens received his devastating leukemia diagnosis during his senior year at UC Riverside.

Panelists discuss how the greatest unmet needs include addressing poor outcomes in specific subsets like TP53-mutant disease, managing the increasingly older population with secondary mutations, and ...